Valanx BioTech develop targeted therapy technology to combat cancer – RebelBio Review

Austrian spin-out Valanx BioTech was founded by Michael Lukesch and Partik Fladischer and may be set to revolutionise the cancer treatment through a new targeted therapy. Over 12.7 million people worldwide discover they have cancer each year and a fu...

Pin It on Pinterest